RPRX

ROYALTY PHARMA PLC

6 superinvestors own RPRX

Based on latest 13F filings — data is 45–90 days delayed

Investor	Fund	Weight	Shares	Value	Quarter	Activity
Pat Dorsey	Dorsey Asset Management	8.70%	2,276,570	$109.2M	2026Q1	Added
Samantha McLemore	Patient Capital Management	6.39%	3,643,716	$174.8M	2026Q1	Added
Torray Funds	Torray Investment Partners	4.54%	645,425	$31.0M	2026Q1	Reduced
Meridian / ArrowMark	Meridian Contrarian Fund	0.47%	366,753	$17.6M	2026Q1	Held
Viking Global Investors	Viking Global Investors	0.27%	2,597,460	$93.6M	2025Q2	Reduced
Warren Buffett	Berkshire Hathaway	0.02%	1,496,372	$58.3M	2022Q1	Reduced

Open-market purchases (P) and sales (S) from SEC Form 4 filings · last 12 months

No open-market insider trades in the last 12 months.

Form 4 filings for option exercises and other transaction types are excluded.

STOCK Act disclosures · last 12 months

Congressional trade data coming soon.

We are sourcing STOCK Act disclosures and will display them here shortly.

What Is SEC Form 4?

Understand the insider trade filings behind RPRX activity.

What Is a 13F Filing?

How superinvestors disclose their quarterly holdings.

Insider Cluster Buying

Why multiple insiders buying together is a strong signal.

Superinvestor Consensus

The most widely held stocks across all tracked institutions.